HOME >> BIOLOGY >> NEWS
Testosterone may help men with multiple sclerosis

Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.

Reporting in the May issue of the journal Archives of Neurology, Dr. Rhonda Voskuhl, the director of UCLAs Multiple Sclerosis Program, and her colleagues have found that the application of a testosterone gel for men with MS reduced symptoms, slowed brain degeneration and increased muscle mass in men with relapsing-remitting multiple sclerosis, the most common form of the disease.

Multiple sclerosis is a progressive disease involving the immune and central nervous systems. MS and many other autoimmune diseases (in which the body attacks its own systems or tissues) are less common in men than in women, said Voskuhl, at a ratio of about three women to one man. Voskuhl has long thought that sex hormones and/or sex chromosomes may be responsible for this enhanced susceptibility. And testosterone has been shown to protect against an MS-like condition in animals.

Voskuhl and Dr. Nancy L. Sicotte, an assistant professor of neurology, conducted a study of testosterone treatment in 10 men with relapsing-remitting MS, which is characterized by periods of neurologic symptoms, such as numbness or difficulty walking, followed by periods of remission. After enrollment in the study, the men, average age 46, entered a six-month pre-treatment phase, during which symptoms were monitored but no therapies were administered. After that, each man applied 10 grams of a gel containing 100 milligrams of testosterone to his upper arms once daily for 12 months.

"After a year we saw an improvement in cognitive performance and a slowing of brain deterioration, said Voskuhl. During the first nine months of the study, the mens symptoms were simply monitored, then followed by just t
'"/>

Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
14-May-2007


Page: 1 2

Related biology news :

1. Testosterone replacement therapy: How safe for aging men?
2. Testosterone therapy may prevent Alzheimers disease
3. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
4. Research teams uncover risk genes for multiple sclerosis
5. First new multiple sclerosis gene found in 30 years
6. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
7. Risk genes for multiple sclerosis uncovered
8. Obesity found to be a risk factor for multiple myeloma
9. Kaposi sarcoma arises independently from multiple cells
10. New collaborative research reveals chimpanzees can sustain multiple-tradition cultures
11. New multiple myeloma treatment induced total remission in 33 percent of patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... ... March 05, 2020 , ... Diagenode, a leading ... Tech (MGI), a subsidiary of global genomics leader BGI Group, today announced a ... States, Europe and Asia Pacific. , Under the terms of the non-exclusive ...
(Date:3/4/2020)... ... 04, 2020 , ... VGXI, Inc., a uniquely specialized CDMO ... as a finalist in the category of Best Contract Manufacturing Organization for the ... of a DNA vaccine against the novel coronavirus, COVID-19, under a CEPI funded ...
(Date:3/2/2020)... TORONTO (PRWEB) , ... March 02, 2020 , ... Toronto-based ... it is soon opening its newest office location just 5 minutes south of Clarksburg ... apple orchard on the property, called End of the Rainbow Orchard, and decided it ...
Breaking Biology News(10 mins):
(Date:3/3/2020)... ... March 03, 2020 , ... Ideal ... the latest breast implant technology at the IMCAS Innovation Shark Tank 2020 in ... the dermatology, plastic surgery, and aesthetic science industries that promise to revolutionize medical ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing ... recently published the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose ... in human milk. These complex carbohydrates are indigestible and therefore function as a ...
(Date:2/21/2020)... ... 20, 2020 , ... The dietary supplement industry now has ... listed on an ingredient panel is actually in their product. As a ... adoption of CertainT, which is designed to protect the intellectual property (IP) of ...
(Date:2/19/2020)... ... February 18, 2020 , ... ... characterizing microbiome populations down to the strain level, recently unveiled a novel DNA ... for efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) ...
Breaking Biology Technology:
Cached News: